Literature DB >> 8871579

Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.

J Schaefer1, S Jackson, D J Dick, D M Turnbull.   

Abstract

Disorders of mitochondrial fatty acid oxidation are a common cause of exercise-induced rhabdomyolysis and myoglobinuria. We report three adult patients from a family with symptoms of recurrent exercise-induced rhabdomyolysis. This presentation closely resembles adult-type carnitine palmitoyltransferase II deficiency except that these patients had an associated peripheral neuropathy. Investigation of fatty acid oxidation in the patients revealed a deficiency of the mitochondrial trifunctional enzyme of beta-oxidation, a newly described fatty acid oxidation disorder with multiorgan involvement and a usually fatal outcome in early childhood. Our cases therefore represent a new phenotype of the disease, which is characterized by recurrent rhabdomyolysis and peripheral neuropathy, but without involvement of other organs, and which is associated with prolonged survival beyond the fourth decade. A low-fat/high-carbohydrate diet proved beneficial in one of the patients, drastically reducing the frequency of rhabdomyolytic episodes. Our findings suggest that mitochondrial trifunctional enzyme deficiency should be considered in patients with recurrent episodes of myoglobinuria and peripheral neuropathy presenting in later life.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871579     DOI: 10.1002/ana.410400409

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.

Authors:  Annie M Behrend; Cary O Harding; James D Shoemaker; Dietrich Matern; David J Sahn; Diane L Elliot; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

2.  Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis.

Authors:  Khalid Al-Thihli; Graham Sinclair; Sandra Sirrs; Michelle Mezei; Judie Nelson; Hilary Vallance
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

Review 3.  Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

Authors:  R J Wanders; P Vreken; M E den Boer; F A Wijburg; A H van Gennip; L IJlst
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  Adolescent myopathic presentation in two sisters with very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B Merinero; S I Pascual Pascual; C Pérez-Cerdá; J Gangoiti; M Castro; M J Garcia; I Pascual Castroviejo; C Vianey-Saban; B Andresen; N Gregersen; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

5.  Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy.

Authors:  Andreu Viader; Yo Sasaki; Sungsu Kim; Amy Strickland; Cayce S Workman; Kui Yang; Richard W Gross; Jeffrey Milbrandt
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

6.  scully, an essential gene of Drosophila, is homologous to mammalian mitochondrial type II L-3-hydroxyacyl-CoA dehydrogenase/amyloid-beta peptide-binding protein.

Authors:  L Torroja; D Ortuño-Sahagún; A Ferrús; B Hämmerle; J A Barbas
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

7.  What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?

Authors:  A M Lund; M A Dixon; P Vreken; J V Leonard; A A M Morris
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

Review 8.  Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.

Authors:  Simon E Olpin
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.